Bangladesh's Incepta partners with British firm ViraCorp to produce nasal COVID vaccine

Bangladesh’s Incepta partners with British firm ViraCorp to produce nasal COVID vaccine

Related Keywords

China ,Bangladesh ,Chinese ,Bangladeshi ,Abdul Muktadir ,Muhammad Munir ,Incepta Vaccine ,Lancaster University ,Incepta Vaccine Limited ,Globe Biotech ,R Muhammad Munir ,Iracorp ,Chief Scientific Officer ,Coronavirus ,Covid 19 ,Nasal Vaccine ,